Dental and Medical Problems

Dent. Med. Probl.
Index Copernicus (ICV 2019) – 118.76
MNiSW – 20
CiteScore (2020) – 1.2
Average rejection rate (2020) – 88.71%
ISSN 1644-387X (print)
ISSN 2300-9020 (online)
Periodicity – quarterly

Download PDF

Dental and Medical Problems

2015, vol. 52, nr 3, July-September, p. 356–362

Publication type: clinical case

Language: English

Creative Commons BY-NC-ND 3.0 Open Access

Dental Abnormalities in a Patient Treated for Neuroblastoma

Zaburzenia rozwojowe uzębienia u pacjenta leczonego z powodu rozpoznania nerwiaka zarodkowego

Anna Jodłowska1,A,B,C,D, Michał Tarnawski2,B,C, Lidia Postek-Stefańska1,E,F

1 Department of Pediatric Dentistry, Medical University of Silesia in Katowice, Zabrze, Poland

2 Private Practice, Katowice, Poland


Long-term cancer survivors require additional diagnostics and care due to the late effects of the neoplasm and its treatment. The type and intensity of the dental pathological changes can be determined among others by the type and dose of the cytostatic drug applied as well as the duration of oncological treatment. Most abnormalities occur in the period of intense development of tooth buds, i.e. before 5 years of age. Neuroblastoma is a solid tumor arising from neural crest cells. It occurs most often in the retroperitoneum and is diagnosed very early, at approximately 2–3 years of age. Chemotherapy administered at that stage of life may subsequently affect dental development. This paper presents a case report of a 13-year-old male patient with microdontia of the four first premolars. The patient was treated with long-term chemotherapy at the time of the first premolar crowns’ development. The treatment of neuroblastoma probably caused these adverse effects. Moreover, clinical examination has revealed enamel anatomical abnormalities of the permanent incisors, canines and first molars.

Key words

neuroblastoma, chemotherapy, dental abnormalities, microdontia, late effects

Słowa kluczowe

nerwiak zarodkowy, chemioterapia, zaburzenia zębowe, mikrodoncja, późne następstwa

References (23)

  1. Remmers D., Bokkerink J.P.M., Katsaros C.: Microdontia after chemotherapy in a child treated for neuroblastoma. Orthod. Craniofacial Res. 2006, 9, 206–210.
  2. Holtta P., Hovi L., Saarinen-Pihcala U.M., Peltola J., Alaluusua S.: Disturbed root development of permanent teeth after pediatric stem cell transplantation. Cancer, 2005, 103, 1484–1493.
  3. Marec-Berard P., Chaux-Bodard A.G., Lagrange H., Gourmet R., Bergeron C.: Long-term effects of chemotherapy on dental status in children treated for nephroblastoma. Pediatr Hemat Oncol. 2005, 22, 581–588.
  4. Macleod R.I., Welbury R.R., Soames J.V.: Effects of cytotoxic chemotherapy on dental development. J. Royal Soc. Med. 1987, 80, 207–209.
  5. Rosenberg S.W., Kolodney H., Wong G.Y., Murphy M.L.: Altered dental root development in long-term survivors of pediatric acute lymphoblastic leukemia. Cancer, 1987, 59, 1640–1648.
  6. Holtta P., Alaluusua S., Saarinen-Pihkala U.M., Peltola J., Hovi L.: Agenesis and microdontia of permanent teeth as late adverse effects after stem cell transplantation in young children. Cancer, 2005,103, 181–190.
  7. Nasman M., Bjork O., Soderhall S., Ringden O., Dahllof G.: Disturbances in the oral cavity in pediatric longterm survivors after different forms of antineoplastic therapy. Pediatr. Dent. 1994, 16, 217–223.
  8. Avsar A., Elli M., Darka O., Pinarli G.: Long-term effects of chemotherapy on caries formation, dental development and salivary factors in childhood cancer survivors. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2007, 104, 781–789.
  9. Oguz A., Cetiner S., Karadeniz C., Alpaslan G., Pinarli G.: Long-term effects of chemotherapy on orodental structures in children with non-Hodgkin’s lymphoma. Eur. J. Oral Sci. 2004, 112, 8–11.
  10. Anton E.: Ultrastructural study of the effect of cyclophosphamide on the growth area of incisor teeth of DBA/2 and C57BL/6 mice. Int. J. Exp. Path. 1996, 77, 83–88.
  11. Dahl J.E.: Influence of doxorubicin on rat incisor mesenchymal cells. Scand. J. Dent. Res. 1984, 92, 6–13.
  12. Stene T., Stromme Koppang H.: Autoradiographic investigation of dentin production in rat incisors after vincristine administration. Scand. J. Dent. Res. 1980, 88, 104–112.
  13. Vahlsing H.L., Kim S.-K., Feringa E.R.: Cyclophosphamide-induced abnormalities in the incisors of the rat. J. Dent. Res. 1977, 56, 809–816.
  14. Holtta P., Alaluusua S., Saarinen-Pihkala U.M., Wolf J., Nystrom M., Hovi L.: Long-term adverse effects on dentition in children with high-dose chemotherapy and autologous stem cell transplantation with or without total body irradiation. Bone Marrow Transplant. 2002, 29, 121–127.
  15. Kaste S.C., Hopkins K.P., Bowman L.C., Santana V.M.: Dental abnormalities in children treated for neuroblastoma. Med. Pediatr. Oncol. 1998, 30, 22–27.
  16. Kaste S.C., Hopkins K.P., Jesse J.J. III: Abnormal odontogenesis in children treated with radiation and chemotherapy: imaging findings. A.J.R. 1994, 162, 1407–1411.
  17. Maguire A., Craft A.W., Evans R.G.B., Amineddine H., Kernahan J., Macleod R.I., Murray J.J., Welbury R.R.: The long-term effects of treatment on the dental condition of children surviving malignant disease. Cancer, 1987, 60, 2570–2575.
  18. Kushner B.H.: Neuroblastoma: a disease requiring a multitude of imaging studies. J. Nucl. Med. 2004, 45, 1172–1188.
  19. Goldsby R.E., Matthay K.K.: Neuroblastoma. Evolving therapies for a disease with many faces. Pediatr. Drugs 2004, 6, 107–122.
  20. Weinstein J.L., Katzenstein H.M., Cohn S.L.: Advances in the diagnosis and treatment of neuroblastoma. Oncolog. 2003, 8, 278–292.
  21. Henry M.C.W., Tashjian D.B., Breuer C.K.: Neuroblastoma update. Curr. Opin. Oncol. 2005, 17, 19–23.
  22. Cameron A. C., Widmer R.P.: Stomatologia dziecięca. Urban and Partner, Wrocław 2005, 1st ed., 381.
  23. Kmieć Z.: Histologia zęba i jamy ustnej. Skryptor, Gdańsk 2003, 1st ed., 7–58.